NCT04681183

Brief Summary

This pilot research study is being performed to learn more about pain and look at how pain changes brain chemistry and function. The research team would like to learn new information to better control chronic pain after surgery. This information collected in this research will be used to plan possible future visits. Participants in this study are being asked to participate because they are scheduled for an upcoming surgery. The research team would like to observe them before and after their surgery.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
13

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 14, 2020

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

December 18, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 23, 2020

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

March 13, 2024

Status Verified

March 1, 2024

Enrollment Period

4 years

First QC Date

December 18, 2020

Last Update Submit

March 12, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Chronic post-surgical pain; Unabbreviated scale title "Chronic post-surgical pain scores"

    Pain scores over prior 2 weeks reported 2-6 months after surgery; minimum value = 0, maximum value = 10; higher score means more severe pain

    2-6 months after surgery

Secondary Outcomes (3)

  • Evoked pressure pain measures; Unabbreviated scale title "Evoked pressure pain measures"

    1-2 weeks after surgery

  • Resting state connectivity

    1 - 8 weeks before surgery

  • Correlation of DNAm of specified gene regions with outcomes

    1-8 weeks before surgery or day of surgery

Eligibility Criteria

Age8 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing chest surgery (thoracotomy, thoracoscopy, Nuss procedure, pectus surgery, mastectomy), spine surgery, amputation, hernia repair or hip/knee replacement in the hospital.

You may qualify if:

  • Male or female aged ≥ 8 yrs of age
  • English speaking;
  • Healthy (Defined as American Society of Anesthesiologists Physical Status 1 or 2)
  • Ability to provide assent/consent/parent permission.
  • Scheduled to undergo chest surgery (thoracotomy, thoracoscopy, Nuss procedure, pectus surgery, mastectomy), spine surgery, amputation, hernia repair or hip/knee replacement.

You may not qualify if:

  • History of chronic pain conditions including migraines
  • Use of opioids chronically or for major surgery within the 6 months prior to enrollment
  • Severe obesity (BMI\>35 kg/m2)
  • Taking no more than two concomitant medications known to induce or inhibit CYP2D6 activity, including paroxetine, fluoxetine, cimetidine, and duloxetine or other medications used to treat attention deficit hyperactivity disorder (medications containing amphetamine or methylphenidate).
  • Use of hormonal contraceptives
  • Use of medications that may alter pain sensitivity (e.g. gabapentin,/pregabalin amitryptiline/other antidepressants, clonidine).
  • Active or history of renal/liver problems or congenital cardiac disease
  • Diagnosed developmental delay
  • Pregnant or lactating females
  • Any skin condition that prevents cuff application
  • History of seizures
  • Claustrophobia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cincinnati Children's Hospital

Cincinnati, Ohio, 45229, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

DNA will be isolated from blood samples and be used for pyrosequencing studies to obtain DNA methylation information for a specified set of genes or use of the Methylation EPIC array. DNA samples gathered will be held for future analysis.

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Vidya Chidambaran, MD

    Children's Hospital Medical Center, Cincinnati

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 18, 2020

First Posted

December 23, 2020

Study Start

December 14, 2020

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

March 13, 2024

Record last verified: 2024-03

Locations